EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pharmacogenetics Governance for Youth Mental Health: A Scoping Review of Policy Across 13 Countries

Prosper Mandela Amaltinga Awuni, Bishnu B. Bajgain, Diane L. Lorenzetti, Gina Dimitropoulos, Paul D. Arnold, Jennifer Zwicker, Chad Bousman

Clinical Pharmacology & Therapeutics · 2026-11-09

DOI: 10.1002/cpt.70562 ↗
AbstractBibliografische Angaben

Abstract

Pharmacogenetics (PGx) testing could improve psychotropic prescribing for children and young people, yet youth‐specific policy guidance remains scarce. This review characterizes the international PGx policy landscape for youth mental health across 13 countries. From 940 records, 20 policy documents met inclusion criteria, yielding 190 passages for thematic analysis using the GE 3 LS framework. We found that 75% of policies primarily focused on guiding medication prescribing in adult populations, with limited consideration of youth populations; only one (5%) was designed specifically for youth. Three‐quarters of documents originated from professional organizations rather than governments, indicating a structural governance vacuum. An “inverted pyramid” of policy priorities was identified, with scientific (Genomics, 29.5%) and implementation (Social, 24.7%) considerations dominating over weak economic (7.9%) and legal (14.2%) foundations. Policy coverage primarily focused on medications used in adult populations (antidepressants 80%; cardiovascular 85%), with limited consideration of youth populations; anxiolytics, relevant in pediatric practice, were covered in only 5% of documents. Policymakers must prioritize enforceable, youth‐centered legislation to address these governance failures.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →